Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT81 | Cell Line | A549 | Homo sapiens | ED50 | = | 7.5 | nM | 1613753 |
NPT83 | Cell Line | MCF7 | Homo sapiens | ED50 | = | 9.7 | nM | 1613753 |
NPT139 | Cell Line | HT-29 | Homo sapiens | ED50 | = | 6.9 | nM | 1613753 |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | ED50 | = | 8.8 | nM | 1613753 |
NPT3958 | Cell Line | MLM | ED50 | > | 0.025 | nM | 1613753 | |
NPT875 | Organism | Bos taurus | Bos taurus | IC50 | > | 40000 | nM | 1613753 |
NPT32 | Organism | Mus musculus | Mus musculus | IC50 | = | 22000 | nM | 10714491 |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 2.77 | ug/ml | 12036362 |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | GI50 | = | 0.35 | ug/ml | 12036362 |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | = | 5.6 | ug/ml | 12036362 |
NPT2 | Others | Unspecified | GI50 | = | 0.62 | ug/ml | 12036362 | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 1.5 | ug/ml | 12036362 |
NPT1603 | Individual Protein | Cytochrome P450 1A1 | Homo sapiens | IC50 | = | 830 | nM | 11754588 |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | IC50 | = | 6200 | nM | 11754588 |
NPT1604 | Individual Protein | Cytochrome P450 1B1 | Homo sapiens | IC50 | = | 790 | nM | 11754588 |
NPT2 | Others | Unspecified | Ratio | = | 1.1 | 11754588 | ||
NPT2 | Others | Unspecified | Ratio | = | 7.9 | 11754588 | ||
NPT3959 | Individual Protein | Aryl hydrocarbon receptor | Oryctolagus cuniculus | Ki | = | 7.7 | nM | 15634023 |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | Ki | = | 261 | nM | 15634023 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | = | 1200 | nM | 16250636 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 2500 | nM | 16686543 |
NPT116 | Cell Line | HL-60 | Homo sapiens | AC50 | = | 4000 | nM | 16686543 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | IC50 | = | 8000 | nM | 16686543 |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | AC50 | = | 50000 | nM | 16686543 |
NPT3960 | Individual Protein | Bcr/Abl fusion protein | Homo sapiens | IC50 | = | 10000 | nM | 16686543 |
NPT3960 | Individual Protein | Bcr/Abl fusion protein | Homo sapiens | AC50 | = | 25000 | nM | 16686543 |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 2500 | nM | 16580204 |
NPT116 | Cell Line | HL-60 | Homo sapiens | AC50 | = | 4000 | nM | 16580204 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 10300 | nM | 17000031 |
NPT2 | Others | Unspecified | Activity | = | 94 | % | 17316918 | |
NPT2 | Others | Unspecified | Activity | < | 0.001 | nM | 17316918 | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 500 | ug/ml | 15043439 |
NPT116 | Cell Line | HL-60 | Homo sapiens | Activity | = | 32.23 | % | 19271734 |
NPT2 | Others | Unspecified | IC50 | = | 28300 | nM | 18487053 | |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | GI50 | = | 0.35 | ug/ml | 19719153 |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | = | 0.56 | ug/ml | 19719153 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 0.62 | ug/ml | 19719153 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 1.5 | ug/ml | 19719153 |
NPT660 | Cell Line | SW480 | Homo sapiens | IC50 | = | 54000 | nM | 20395019 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 16100 | nM | 20627379 |
NPT492 | Cell Line | Caco-2 | Homo sapiens | IC50 | = | 11950 | nM | 20627379 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 19.5 | ug | 20627379 |
NPT139 | Cell Line | HT-29 | Homo sapiens | Activity | = | 0.57 | ug | 20627379 |
NPT139 | Cell Line | HT-29 | Homo sapiens | Activity | = | 590.3 | mm3 | 20627379 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 5700 | nM | 21215623 |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 1100 | nM | 21215623 |
NPT2 | Others | Unspecified | IC50 | = | 5200 | nM | 21215623 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | Ratio IC50 | = | 1.9 | 21215623 | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 0.4 | 21215623 | ||
NPT71 | Cell Line | HEK293 | Homo sapiens | FC | = | 4 | 21880495 | |
NPT182 | Individual Protein | Protein kinase C alpha | Homo sapiens | Activity | = | 31.9 | % | 21880495 |
NPT182 | Individual Protein | Protein kinase C alpha | Homo sapiens | Activity | = | 20 | % | 21880495 |
NPT182 | Individual Protein | Protein kinase C alpha | Homo sapiens | EC50 | = | 1560000 | nM | 21880495 |
NPT2 | Others | Unspecified | Ratio | = | 0.04 | 22088309 | ||
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 9954.05 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 7079.46 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 6982.32 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 18238.96 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 8072.35 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 2558.59 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 3539.97 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 4226.69 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 6123.5 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 4325.14 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 6180.16 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 3296.1 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 4508.17 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 4920.4 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 4064.43 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 22080.05 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 14028.14 | nM | PubChem BioAssay data set | |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 3793.15 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 20749.14 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 4236.43 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 12618.28 | nM | PubChem BioAssay data set | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 6309.57 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 4977.37 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 2679.17 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 4168.69 | nM | PubChem BioAssay data set | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 8433.35 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 6531.31 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 6486.34 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 3556.31 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 18879.91 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 6698.85 | nM | PubChem BioAssay data set | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 3147.75 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 6067.36 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 9794.9 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 6324.12 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 4819.48 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 4570.88 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 4168.69 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 7925.01 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 22438.82 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 4140 | nM | PubChem BioAssay data set | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 4864.07 | nM | PubChem BioAssay data set | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 3499.45 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 3732.5 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 4602.57 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 3564.51 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 4375.22 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 6441.69 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 9660.51 | nM | PubChem BioAssay data set | |
NPT577 | Cell Line | RXF 631 | Homo sapiens | GI50 | 4197.59 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 4623.81 | nM | PubChem BioAssay data set | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 3981.07 | nM | PubChem BioAssay data set | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 5284.45 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 3971.92 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 5432.5 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 3881.5 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 3819.44 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 3054.92 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 3411.93 | nM | PubChem BioAssay data set | |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 24322.04 | nM | PubChem BioAssay data set | |
NPT155 | Individual Protein | Aryl hydrocarbon receptor | Homo sapiens | Ki | = | 130016957.8 | nM | 10.1007/s00044-007-9055-2 |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 6390 | nM | 10.1007/s00044-012-0159-y |
NPT2 | Others | Unspecified | IC50 | = | 4830 | nM | 10.1007/s00044-012-0159-y | |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 8410 | nM | 10.1007/s00044-012-0159-y |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | IC50 | = | 26700 | nM | 23547843 |
NPT857 | Cell Line | LLC-PK1 | Sus scrofa | IC50 | = | 20000 | nM | 23547843 |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | = | 13300 | nM | 23547843 |
NPT916 | Cell Line | SK-MEL | Homo sapiens | IC50 | = | 12200 | nM | 23547843 |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | IC50 | = | 55500 | nM | 23547843 |
NPT457 | Cell Line | BT-549 | Homo sapiens | IC50 | = | 15600 | nM | 23547843 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 17700 | nM | 23547843 |
NPT366 | Individual Protein | Quinone reductase 2 | Homo sapiens | IC50 | = | 14600 | nM | 23953689 |
NPT472 | Individual Protein | Vanilloid receptor | Homo sapiens | IC50 | > | 10000 | nM | 26750258 |
NPT1534 | Individual Protein | Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus | EC50 | = | 1700 | nM | 26750258 |
NPT1534 | Individual Protein | Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus | IC50 | = | 3000 | nM | 26750258 |
NPT65 | Cell Line | HepG2 | Homo sapiens | Activity | = | 42 | % | 26850006 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 34 | % | 26850006 |
NPT32 | Organism | Mus musculus | Mus musculus | Activity | = | 19 | % | 26850006 |
NPT2 | Others | Unspecified | Ratio IC50 | = | 0.74 | 26850006 | ||
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 1667 | nM | 26850006 |
NPT324 | Individual Protein | Cyclooxygenase-1 | Ovis aries | IC50 | = | 1228 | nM | 26850006 |
NPT2 | Others | Unspecified | Ratio | = | 0.82 | 27426305 | ||
NPT2 | Others | Unspecified | Ratio | = | 0.85 | 27426305 | ||
NPT2 | Others | Unspecified | Ratio | = | 0.31 | 27426305 | ||
NPT2 | Others | Unspecified | Ratio | = | -0.15 | 27426305 | ||
NPT882 | Cell Line | Thymocytes | Ratio | < | 5 | 27426305 | ||
NPT882 | Cell Line | Thymocytes | Ratio | = | 5 | 27426305 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC82016 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9802 | High Similarity | NPC35543 |
0.9706 | High Similarity | NPC245115 |
0.9528 | High Similarity | NPC180508 |
0.9528 | High Similarity | NPC228287 |
0.9519 | High Similarity | NPC2682 |
0.9352 | High Similarity | NPC123948 |
0.934 | High Similarity | NPC280606 |
0.9266 | High Similarity | NPC474933 |
0.9245 | High Similarity | NPC296920 |
0.9245 | High Similarity | NPC90520 |
0.9174 | High Similarity | NPC141090 |
0.9151 | High Similarity | NPC303521 |
0.9151 | High Similarity | NPC94045 |
0.9099 | High Similarity | NPC254625 |
0.9099 | High Similarity | NPC475961 |
0.9083 | High Similarity | NPC53906 |
0.9065 | High Similarity | NPC203924 |
0.9 | High Similarity | NPC203113 |
0.8991 | High Similarity | NPC22610 |
0.8991 | High Similarity | NPC276737 |
0.8938 | High Similarity | NPC472596 |
0.8938 | High Similarity | NPC102639 |
0.8938 | High Similarity | NPC166759 |
0.8929 | High Similarity | NPC15805 |
0.8919 | High Similarity | NPC69261 |
0.8919 | High Similarity | NPC195466 |
0.8919 | High Similarity | NPC33270 |
0.8919 | High Similarity | NPC470759 |
0.8919 | High Similarity | NPC127894 |
0.8919 | High Similarity | NPC15860 |
0.8919 | High Similarity | NPC219070 |
0.8909 | High Similarity | NPC464 |
0.8909 | High Similarity | NPC185541 |
0.8899 | High Similarity | NPC204120 |
0.8879 | High Similarity | NPC165386 |
0.886 | High Similarity | NPC476633 |
0.886 | High Similarity | NPC477886 |
0.885 | High Similarity | NPC474565 |
0.8829 | High Similarity | NPC150624 |
0.8829 | High Similarity | NPC54507 |
0.8829 | High Similarity | NPC85292 |
0.8829 | High Similarity | NPC229147 |
0.8829 | High Similarity | NPC114064 |
0.8783 | High Similarity | NPC262253 |
0.8783 | High Similarity | NPC473411 |
0.8783 | High Similarity | NPC261661 |
0.8783 | High Similarity | NPC71579 |
0.8774 | High Similarity | NPC164576 |
0.8761 | High Similarity | NPC184302 |
0.8761 | High Similarity | NPC226629 |
0.8739 | High Similarity | NPC167934 |
0.8739 | High Similarity | NPC808 |
0.8716 | High Similarity | NPC255068 |
0.8707 | High Similarity | NPC136319 |
0.8707 | High Similarity | NPC282496 |
0.8707 | High Similarity | NPC233526 |
0.8673 | High Similarity | NPC131118 |
0.8673 | High Similarity | NPC190514 |
0.8632 | High Similarity | NPC270030 |
0.8624 | High Similarity | NPC168657 |
0.8624 | High Similarity | NPC106141 |
0.8596 | High Similarity | NPC172253 |
0.8596 | High Similarity | NPC59561 |
0.8585 | High Similarity | NPC474603 |
0.8585 | High Similarity | NPC12987 |
0.8584 | High Similarity | NPC221549 |
0.8584 | High Similarity | NPC304208 |
0.8584 | High Similarity | NPC244816 |
0.8584 | High Similarity | NPC52464 |
0.8584 | High Similarity | NPC50521 |
0.8559 | High Similarity | NPC60885 |
0.8559 | High Similarity | NPC57490 |
0.8559 | High Similarity | NPC82483 |
0.8559 | High Similarity | NPC233410 |
0.8559 | High Similarity | NPC472093 |
0.8559 | High Similarity | NPC116907 |
0.8559 | High Similarity | NPC298757 |
0.8559 | High Similarity | NPC265483 |
0.8559 | High Similarity | NPC113495 |
0.8559 | High Similarity | NPC117214 |
0.8559 | High Similarity | NPC193544 |
0.8559 | High Similarity | NPC475169 |
0.8559 | High Similarity | NPC105031 |
0.8559 | High Similarity | NPC299584 |
0.8559 | High Similarity | NPC105925 |
0.8559 | High Similarity | NPC208950 |
0.8559 | High Similarity | NPC221077 |
0.8559 | High Similarity | NPC234400 |
0.8559 | High Similarity | NPC203133 |
0.8559 | High Similarity | NPC251855 |
0.8559 | High Similarity | NPC17943 |
0.8534 | High Similarity | NPC75713 |
0.8522 | High Similarity | NPC10932 |
0.8522 | High Similarity | NPC232084 |
0.8522 | High Similarity | NPC61516 |
0.8522 | High Similarity | NPC247364 |
0.8487 | Intermediate Similarity | NPC18924 |
0.8487 | Intermediate Similarity | NPC244364 |
0.8487 | Intermediate Similarity | NPC78974 |
0.8487 | Intermediate Similarity | NPC112571 |
0.8487 | Intermediate Similarity | NPC223136 |
0.8487 | Intermediate Similarity | NPC285725 |
0.8487 | Intermediate Similarity | NPC103823 |
0.8487 | Intermediate Similarity | NPC170485 |
0.8487 | Intermediate Similarity | NPC214406 |
0.8487 | Intermediate Similarity | NPC28730 |
0.8487 | Intermediate Similarity | NPC50683 |
0.8487 | Intermediate Similarity | NPC44748 |
0.8462 | Intermediate Similarity | NPC77789 |
0.8462 | Intermediate Similarity | NPC18128 |
0.8462 | Intermediate Similarity | NPC41562 |
0.8455 | Intermediate Similarity | NPC475852 |
0.8448 | Intermediate Similarity | NPC199023 |
0.844 | Intermediate Similarity | NPC75440 |
0.8435 | Intermediate Similarity | NPC308217 |
0.8421 | Intermediate Similarity | NPC33271 |
0.8421 | Intermediate Similarity | NPC259638 |
0.8417 | Intermediate Similarity | NPC324112 |
0.8417 | Intermediate Similarity | NPC282000 |
0.8417 | Intermediate Similarity | NPC194841 |
0.8417 | Intermediate Similarity | NPC124452 |
0.8417 | Intermediate Similarity | NPC159968 |
0.8417 | Intermediate Similarity | NPC474119 |
0.8417 | Intermediate Similarity | NPC293054 |
0.8417 | Intermediate Similarity | NPC246620 |
0.8417 | Intermediate Similarity | NPC169474 |
0.8417 | Intermediate Similarity | NPC82679 |
0.8417 | Intermediate Similarity | NPC473221 |
0.8417 | Intermediate Similarity | NPC236791 |
0.8417 | Intermediate Similarity | NPC242032 |
0.8417 | Intermediate Similarity | NPC127587 |
0.8417 | Intermediate Similarity | NPC74817 |
0.8417 | Intermediate Similarity | NPC210355 |
0.8411 | Intermediate Similarity | NPC241224 |
0.8396 | Intermediate Similarity | NPC300166 |
0.839 | Intermediate Similarity | NPC84086 |
0.839 | Intermediate Similarity | NPC197757 |
0.839 | Intermediate Similarity | NPC228922 |
0.839 | Intermediate Similarity | NPC95168 |
0.839 | Intermediate Similarity | NPC474160 |
0.8362 | Intermediate Similarity | NPC222175 |
0.835 | Intermediate Similarity | NPC471581 |
0.8348 | Intermediate Similarity | NPC63083 |
0.8348 | Intermediate Similarity | NPC474612 |
0.8347 | Intermediate Similarity | NPC474651 |
0.8347 | Intermediate Similarity | NPC31707 |
0.8347 | Intermediate Similarity | NPC186843 |
0.8347 | Intermediate Similarity | NPC98631 |
0.8347 | Intermediate Similarity | NPC222127 |
0.8347 | Intermediate Similarity | NPC210674 |
0.8347 | Intermediate Similarity | NPC206615 |
0.8347 | Intermediate Similarity | NPC82862 |
0.8347 | Intermediate Similarity | NPC470213 |
0.8347 | Intermediate Similarity | NPC474623 |
0.8333 | Intermediate Similarity | NPC193067 |
0.8333 | Intermediate Similarity | NPC88297 |
0.8333 | Intermediate Similarity | NPC186845 |
0.8333 | Intermediate Similarity | NPC9891 |
0.8333 | Intermediate Similarity | NPC223953 |
0.8333 | Intermediate Similarity | NPC76451 |
0.8333 | Intermediate Similarity | NPC82299 |
0.8319 | Intermediate Similarity | NPC122792 |
0.8319 | Intermediate Similarity | NPC206487 |
0.8319 | Intermediate Similarity | NPC5796 |
0.8319 | Intermediate Similarity | NPC228503 |
0.8319 | Intermediate Similarity | NPC294156 |
0.8319 | Intermediate Similarity | NPC228972 |
0.8319 | Intermediate Similarity | NPC138248 |
0.8319 | Intermediate Similarity | NPC256015 |
0.8317 | Intermediate Similarity | NPC8002 |
0.8317 | Intermediate Similarity | NPC99886 |
0.8317 | Intermediate Similarity | NPC259134 |
0.8317 | Intermediate Similarity | NPC177844 |
0.8317 | Intermediate Similarity | NPC302546 |
0.8305 | Intermediate Similarity | NPC36016 |
0.8305 | Intermediate Similarity | NPC100099 |
0.8305 | Intermediate Similarity | NPC194626 |
0.8305 | Intermediate Similarity | NPC74137 |
0.8305 | Intermediate Similarity | NPC288238 |
0.8302 | Intermediate Similarity | NPC248573 |
0.8302 | Intermediate Similarity | NPC275053 |
0.8302 | Intermediate Similarity | NPC161571 |
0.8286 | Intermediate Similarity | NPC470161 |
0.8279 | Intermediate Similarity | NPC190144 |
0.8279 | Intermediate Similarity | NPC218856 |
0.8279 | Intermediate Similarity | NPC58164 |
0.8279 | Intermediate Similarity | NPC226788 |
0.8279 | Intermediate Similarity | NPC210623 |
0.8279 | Intermediate Similarity | NPC476968 |
0.8279 | Intermediate Similarity | NPC285339 |
0.8279 | Intermediate Similarity | NPC471519 |
0.8279 | Intermediate Similarity | NPC10225 |
0.8279 | Intermediate Similarity | NPC170844 |
0.8279 | Intermediate Similarity | NPC222004 |
0.8279 | Intermediate Similarity | NPC190629 |
0.8279 | Intermediate Similarity | NPC273295 |
0.8279 | Intermediate Similarity | NPC470258 |
0.8279 | Intermediate Similarity | NPC228769 |
0.8279 | Intermediate Similarity | NPC471518 |
0.8279 | Intermediate Similarity | NPC469951 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC82016 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8783 | High Similarity | NPD2981 | Phase 2 |
0.8707 | High Similarity | NPD2983 | Phase 2 |
0.8707 | High Similarity | NPD2982 | Phase 2 |
0.8417 | Intermediate Similarity | NPD3018 | Phase 2 |
0.8302 | Intermediate Similarity | NPD1242 | Phase 1 |
0.8279 | Intermediate Similarity | NPD3027 | Phase 3 |
0.823 | Intermediate Similarity | NPD5283 | Phase 1 |
0.819 | Intermediate Similarity | NPD1548 | Phase 1 |
0.8067 | Intermediate Similarity | NPD1610 | Phase 2 |
0.8049 | Intermediate Similarity | NPD4908 | Phase 1 |
0.8036 | Intermediate Similarity | NPD5451 | Approved |
0.7949 | Intermediate Similarity | NPD5536 | Phase 2 |
0.792 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.784 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7787 | Intermediate Similarity | NPD4749 | Approved |
0.7778 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7769 | Intermediate Similarity | NPD3539 | Phase 1 |
0.7768 | Intermediate Similarity | NPD3134 | Approved |
0.776 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7742 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.771 | Intermediate Similarity | NPD3540 | Phase 1 |
0.768 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7672 | Intermediate Similarity | NPD5535 | Approved |
0.7667 | Intermediate Similarity | NPD1651 | Approved |
0.7656 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7656 | Intermediate Similarity | NPD1613 | Approved |
0.7632 | Intermediate Similarity | NPD2684 | Approved |
0.7623 | Intermediate Similarity | NPD422 | Phase 1 |
0.7586 | Intermediate Similarity | NPD228 | Approved |
0.7568 | Intermediate Similarity | NPD940 | Approved |
0.7568 | Intermediate Similarity | NPD846 | Approved |
0.7544 | Intermediate Similarity | NPD1358 | Approved |
0.754 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7521 | Intermediate Similarity | NPD5585 | Approved |
0.75 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD2796 | Approved |
0.75 | Intermediate Similarity | NPD2934 | Approved |
0.75 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD2933 | Approved |
0.7481 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.748 | Intermediate Similarity | NPD3705 | Approved |
0.7459 | Intermediate Similarity | NPD17 | Approved |
0.7456 | Intermediate Similarity | NPD968 | Approved |
0.7438 | Intermediate Similarity | NPD1182 | Approved |
0.7431 | Intermediate Similarity | NPD2859 | Approved |
0.7431 | Intermediate Similarity | NPD2860 | Approved |
0.7426 | Intermediate Similarity | NPD7124 | Phase 2 |
0.7417 | Intermediate Similarity | NPD3596 | Phase 2 |
0.7414 | Intermediate Similarity | NPD4750 | Phase 3 |
0.7387 | Intermediate Similarity | NPD3020 | Approved |
0.7385 | Intermediate Similarity | NPD1240 | Approved |
0.7377 | Intermediate Similarity | NPD5691 | Approved |
0.7373 | Intermediate Similarity | NPD7843 | Approved |
0.7372 | Intermediate Similarity | NPD4357 | Discontinued |
0.736 | Intermediate Similarity | NPD1669 | Approved |
0.736 | Intermediate Similarity | NPD5327 | Phase 3 |
0.7348 | Intermediate Similarity | NPD6111 | Discontinued |
0.7339 | Intermediate Similarity | NPD1281 | Approved |
0.7333 | Intermediate Similarity | NPD709 | Approved |
0.7333 | Intermediate Similarity | NPD6671 | Approved |
0.7333 | Intermediate Similarity | NPD7157 | Approved |
0.7323 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7317 | Intermediate Similarity | NPD2667 | Approved |
0.7317 | Intermediate Similarity | NPD4626 | Approved |
0.7317 | Intermediate Similarity | NPD2423 | Clinical (unspecified phase) |
0.7317 | Intermediate Similarity | NPD2668 | Approved |
0.7295 | Intermediate Similarity | NPD6580 | Approved |
0.7295 | Intermediate Similarity | NPD6581 | Approved |
0.728 | Intermediate Similarity | NPD1608 | Approved |
0.7279 | Intermediate Similarity | NPD7466 | Approved |
0.7273 | Intermediate Similarity | NPD1607 | Approved |
0.7258 | Intermediate Similarity | NPD3847 | Discontinued |
0.7252 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7241 | Intermediate Similarity | NPD290 | Approved |
0.7236 | Intermediate Similarity | NPD6830 | Clinical (unspecified phase) |
0.7236 | Intermediate Similarity | NPD1357 | Approved |
0.7227 | Intermediate Similarity | NPD821 | Approved |
0.7222 | Intermediate Similarity | NPD4359 | Approved |
0.7214 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7209 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7209 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.719 | Intermediate Similarity | NPD2557 | Approved |
0.7188 | Intermediate Similarity | NPD4624 | Approved |
0.7177 | Intermediate Similarity | NPD2107 | Clinical (unspecified phase) |
0.7177 | Intermediate Similarity | NPD6516 | Phase 2 |
0.7177 | Intermediate Similarity | NPD1778 | Approved |
0.7177 | Intermediate Similarity | NPD5846 | Approved |
0.7168 | Intermediate Similarity | NPD3028 | Approved |
0.7167 | Intermediate Similarity | NPD1241 | Discontinued |
0.7165 | Intermediate Similarity | NPD2922 | Phase 1 |
0.7165 | Intermediate Similarity | NPD1283 | Approved |
0.7164 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7164 | Intermediate Similarity | NPD3748 | Approved |
0.7153 | Intermediate Similarity | NPD3892 | Phase 2 |
0.7143 | Intermediate Similarity | NPD2232 | Approved |
0.7143 | Intermediate Similarity | NPD3972 | Approved |
0.7143 | Intermediate Similarity | NPD2230 | Approved |
0.7143 | Intermediate Similarity | NPD2233 | Approved |
0.7143 | Intermediate Similarity | NPD1840 | Phase 2 |
0.7122 | Intermediate Similarity | NPD5297 | Approved |
0.7119 | Intermediate Similarity | NPD3021 | Approved |
0.7119 | Intermediate Similarity | NPD3022 | Approved |
0.7113 | Intermediate Similarity | NPD7261 | Clinical (unspecified phase) |
0.7111 | Intermediate Similarity | NPD6100 | Approved |
0.7111 | Intermediate Similarity | NPD6099 | Approved |
0.7109 | Intermediate Similarity | NPD3567 | Approved |
0.7109 | Intermediate Similarity | NPD3568 | Approved |
0.7099 | Intermediate Similarity | NPD5110 | Phase 2 |
0.7099 | Intermediate Similarity | NPD5109 | Approved |
0.7099 | Intermediate Similarity | NPD5111 | Phase 2 |
0.7099 | Intermediate Similarity | NPD5718 | Phase 2 |
0.7097 | Intermediate Similarity | NPD3443 | Approved |
0.7097 | Intermediate Similarity | NPD3444 | Approved |
0.7097 | Intermediate Similarity | NPD3445 | Approved |
0.7087 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7087 | Intermediate Similarity | NPD6582 | Phase 2 |
0.708 | Intermediate Similarity | NPD5698 | Clinical (unspecified phase) |
0.7071 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7071 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD4675 | Approved |
0.7063 | Intermediate Similarity | NPD1091 | Approved |
0.7063 | Intermediate Similarity | NPD4678 | Approved |
0.7054 | Intermediate Similarity | NPD7905 | Discontinued |
0.7049 | Intermediate Similarity | NPD6387 | Discontinued |
0.7031 | Intermediate Similarity | NPD1876 | Approved |
0.7031 | Intermediate Similarity | NPD8651 | Approved |
0.7031 | Intermediate Similarity | NPD7258 | Clinical (unspecified phase) |
0.7023 | Intermediate Similarity | NPD7095 | Approved |
0.7021 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7016 | Intermediate Similarity | NPD1894 | Discontinued |
0.7015 | Intermediate Similarity | NPD1772 | Clinical (unspecified phase) |
0.7015 | Intermediate Similarity | NPD4097 | Suspended |
0.7008 | Intermediate Similarity | NPD2231 | Phase 2 |
0.7008 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7007 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7 | Intermediate Similarity | NPD6799 | Approved |
0.7 | Intermediate Similarity | NPD7213 | Phase 3 |
0.6993 | Remote Similarity | NPD6055 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD4005 | Discontinued |
0.6992 | Remote Similarity | NPD4060 | Phase 1 |
0.6992 | Remote Similarity | NPD1558 | Phase 1 |
0.6992 | Remote Similarity | NPD2979 | Phase 3 |
0.6985 | Remote Similarity | NPD2935 | Discontinued |
0.6984 | Remote Similarity | NPD3496 | Discontinued |
0.6981 | Remote Similarity | NPD111 | Approved |
0.6978 | Remote Similarity | NPD2219 | Phase 1 |
0.697 | Remote Similarity | NPD6812 | Clinical (unspecified phase) |
0.697 | Remote Similarity | NPD1296 | Phase 2 |
0.6963 | Remote Similarity | NPD4537 | Clinical (unspecified phase) |
0.6963 | Remote Similarity | NPD4536 | Approved |
0.6963 | Remote Similarity | NPD2200 | Suspended |
0.6963 | Remote Similarity | NPD4538 | Approved |
0.696 | Remote Similarity | NPD3049 | Approved |
0.696 | Remote Similarity | NPD2595 | Approved |
0.696 | Remote Similarity | NPD6382 | Discontinued |
0.696 | Remote Similarity | NPD2594 | Approved |
0.6953 | Remote Similarity | NPD6539 | Approved |
0.6953 | Remote Similarity | NPD2429 | Approved |
0.6953 | Remote Similarity | NPD4129 | Approved |
0.6953 | Remote Similarity | NPD6540 | Phase 3 |
0.6953 | Remote Similarity | NPD6543 | Approved |
0.6953 | Remote Similarity | NPD6542 | Approved |
0.6953 | Remote Similarity | NPD2428 | Approved |
0.695 | Remote Similarity | NPD1424 | Approved |
0.694 | Remote Similarity | NPD5123 | Clinical (unspecified phase) |
0.694 | Remote Similarity | NPD5735 | Approved |
0.694 | Remote Similarity | NPD5124 | Phase 1 |
0.6935 | Remote Similarity | NPD1408 | Clinical (unspecified phase) |
0.6934 | Remote Similarity | NPD1552 | Clinical (unspecified phase) |
0.6934 | Remote Similarity | NPD1550 | Clinical (unspecified phase) |
0.6929 | Remote Similarity | NPD1611 | Approved |
0.6923 | Remote Similarity | NPD9697 | Approved |
0.6918 | Remote Similarity | NPD2393 | Clinical (unspecified phase) |
0.6918 | Remote Similarity | NPD2801 | Approved |
0.6918 | Remote Similarity | NPD7819 | Suspended |
0.6912 | Remote Similarity | NPD4108 | Discontinued |
0.6906 | Remote Similarity | NPD3750 | Approved |
0.6905 | Remote Similarity | NPD2554 | Approved |
0.6905 | Remote Similarity | NPD2556 | Approved |
0.6899 | Remote Similarity | NPD3225 | Approved |
0.6899 | Remote Similarity | NPD6538 | Approved |
0.6899 | Remote Similarity | NPD6541 | Approved |
0.6889 | Remote Similarity | NPD4579 | Clinical (unspecified phase) |
0.6884 | Remote Similarity | NPD1549 | Phase 2 |
0.6881 | Remote Similarity | NPD9295 | Approved |
0.688 | Remote Similarity | NPD2486 | Discontinued |
0.688 | Remote Similarity | NPD7534 | Approved |
0.688 | Remote Similarity | NPD7533 | Approved |
0.6879 | Remote Similarity | NPD1511 | Approved |
0.6875 | Remote Similarity | NPD1432 | Clinical (unspecified phase) |
0.6875 | Remote Similarity | NPD1244 | Clinical (unspecified phase) |
0.6871 | Remote Similarity | NPD3817 | Phase 2 |
0.687 | Remote Similarity | NPD4993 | Discontinued |
0.687 | Remote Similarity | NPD2407 | Clinical (unspecified phase) |
0.6866 | Remote Similarity | NPD4140 | Approved |
0.6861 | Remote Similarity | NPD1551 | Phase 2 |
0.6861 | Remote Similarity | NPD2438 | Suspended |
0.686 | Remote Similarity | NPD1137 | Approved |
PubChem CID   | 5388063 |
ChEMBL   | CHEMBL296411 |
ZINC   |
Molecular Weight:   | 270.13 |
ALogP:   | 0.3124 |
MLogP:   | 3 |
XLogP:   | 4.993 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 27.69 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 0 |
# Rings:   | 2 |
# Heavy Atoms:   | 20 |